THQ · abrdn Healthcare Opportunities Fund
Market Cap
$813.00M
Shares
41.44M
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
abrdn Healthcare Opportunities Fund
Reported 2026-06-30Net Assets
$825,731,795
Total Assets
$1,054,124,193
Holdings
110
Filed
2026-08-28
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc | 91324P102 | 120,631 | NS | $50,137,863 | 6.07% | EC | US |
| VeraDermics Inc | 922967104 | 353,716 | NS | $43,485,845 | 5.27% | EC | US |
| Abbott Laboratories | 002824100 | 433,683 | NS | $39,352,395 | 4.77% | EC | US |
| Merck & Co Inc | 58933Y105 | 283,202 | NS | $36,391,457 | 4.41% | EC | US |
| Medtronic PLC | 000000000 | 449,937 | NS | $35,198,572 | 4.26% | EC | IE |
| Thermo Fisher Scientific Inc | 883556102 | 68,956 | NS | $34,571,780 | 4.19% | EC | US |
| VERADERMICS, INC. | 000000000 | 273,261 | NS | $33,594,707 | 4.07% | EP | US |
| Intuitive Surgical Inc | 46120E602 | 70,415 | NS | $28,002,637 | 3.39% | EC | US |
| CVS Health Corp | 126650100 | 263,513 | NS | $27,260,420 | 3.30% | EC | US |
| Danaher Corp | 235851102 | 139,737 | NS | $26,617,104 | 3.22% | EC | US |
| Oruka Therapeutics Inc | 687604108 | 250,767 | NS | $23,865,495 | 2.89% | EC | US |
| uniQure NV | 000000000 | 496,969 | NS | $22,890,392 | 2.77% | EC | NL |
| Humana Inc | 444859102 | 57,188 | NS | $22,716,217 | 2.75% | EC | US |
| Elevance Health Inc | 036752103 | 54,645 | NS | $21,132,861 | 2.56% | EC | US |
| BioCryst Pharmaceuticals Inc | 09058V103 | 2,088,571 | NS | $20,885,710 | 2.53% | EC | US |
| AbbVie Inc | 00287Y109 | 80,912 | NS | $20,360,696 | 2.47% | EC | US |
| Boston Scientific Corp | 101137107 | 465,063 | NS | $19,848,889 | 2.40% | EC | US |
| Sarepta Therapeutics Inc | 803607100 | 921,334 | NS | $16,556,372 | 2.01% | EC | US |
| NeoGenomics Inc | 64049M209 | 1,069,634 | NS | $15,605,960 | 1.89% | EC | US |
| Insulet Corp | 45784P101 | 101,696 | NS | $15,483,216 | 1.88% | EC | US |
| State Street Global Advisors | 857492706 | 15,337,270 | NS | $15,337,270 | 1.86% | STIV | US |
| Praxis Precision Medicines Inc | 74006W207 | 43,765 | NS | $14,652,084 | 1.77% | EC | US |
| ARS Pharmaceuticals Inc | 82835W108 | 1,805,535 | NS | $14,462,335 | 1.75% | EC | US |
| Abivax SA | 00370M103 | 104,341 | NS | $13,904,482 | 1.68% | EC | FR |
| Alignment Healthcare Inc | 01625V104 | 577,052 | NS | $13,739,608 | 1.66% | EC | US |
| Omega Healthcare Investors Inc | 681936100 | 278,033 | NS | $13,256,613 | 1.61% | EC | US |
| Welltower Inc | 95040Q104 | 57,915 | NS | $13,144,968 | 1.59% | EC | US |
| Vericel Corp | 92346J108 | 294,506 | NS | $13,102,572 | 1.59% | EC | US |
| Bristol-Myers Squibb Co | 110122108 | 221,600 | NS | $12,768,592 | 1.55% | EC | US |
| Molina Healthcare Inc | 60855R100 | 52,318 | NS | $11,965,127 | 1.45% | EC | US |
| GeneDx Holdings Corp | 81663L200 | 171,640 | NS | $11,783,086 | 1.43% | EC | US |
| Acadia Healthcare Co Inc | 00404A109 | 353,243 | NS | $10,431,266 | 1.26% | EC | US |
| Healthpeak Properties Inc | 42250P103 | 485,067 | NS | $10,380,434 | 1.26% | EC | US |
| ABBOTT LABORATORIES | 002824BG4 | 10,498,000 | PA | $10,245,539 | 1.24% | DBT | US |
| Charles River Laboratories International Inc | 159864107 | 44,454 | NS | $10,081,723 | 1.22% | EC | US |
| Ventas Inc | 92276F100 | 110,408 | NS | $9,804,230 | 1.19% | EC | US |
| Oculis Holding AG | 000000000 | 688,455 | NS | $9,548,871 | 1.16% | EC | CH |
| Zoetis Inc | 98978V103 | 131,249 | NS | $9,431,553 | 1.14% | EC | US |
| Sabra Health Care REIT Inc | 78573L106 | 482,214 | NS | $9,407,995 | 1.14% | EC | US |
| Biodesix Inc | 09075X207 | 395,315 | NS | $8,914,353 | 1.08% | EC | US |
| Stryker Corp | 863667101 | 27,571 | NS | $8,680,454 | 1.05% | EC | US |
| CIGNA GROUP/THE | 125523CD0 | 8,250,000 | PA | $8,658,099 | 1.05% | DBT | US |
| ICON PLC | 000000000 | 49,689 | NS | $8,631,476 | 1.05% | EC | IE |
| JOHNSON & JOHNSON | 478160BV5 | 10,130,000 | PA | $8,090,851 | 0.98% | DBT | US |
| PFIZER INC | 717081ET6 | 8,100,000 | PA | $7,911,454 | 0.96% | DBT | US |
| GE HealthCare Technologies Inc | 36266G107 | 121,807 | NS | $7,796,866 | 0.94% | EC | US |
| Waters Corp | 941848103 | 20,517 | NS | $7,694,696 | 0.93% | EC | US |
| McKesson Corp | 58155Q103 | 9,893 | NS | $7,475,151 | 0.91% | EC | US |
| Myriad Genetics Inc | 62855J104 | 1,308,933 | NS | $7,474,007 | 0.91% | EC | US |
| Disc Medicine Inc | 254604101 | 100,151 | NS | $7,325,044 | 0.89% | EC | US |
Showing 1–50 of 110 holdings
Key facts
CIK
1604522
CUSIP
879105104
13F (30d)
68 filings
57 filers
Visit website
Investor relations